Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950138-19-000231
Filing Date
2019-04-03
Accepted
2019-04-03 18:13:34
Documents
1
Period of Report
2019-04-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 7032
  Complete submission text file 0000950138-19-000231.txt   8427
Mailing Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG
Business Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG 44-017-8463-6700
Mallinckrodt plc (Issuer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1228
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BAXALTA INCORPORATED 1200 LAKESIDE DRIVE BANNOCKBURN IL 60015
Business Address
ROSA-BJORKESON DAGMAR (Reporting) CIK: 0001643934 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35803 | Film No.: 19730486